Sandy Macrae Sangamo Therapeutics, Inc (SGMO) insider trading activity

SGMO Quotes by TradingView

Sandy Macrae is PRESIDENT, CEO AND DIRECTOR of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 2.05 Million shares of SGMO, which is worth approximately $901,794. The most recent transaction as insider was on Feb 25, 2022, when has been sold 224,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.05M
6.16% 3M change
18.3% 12M change
Total Value Held $901,794

Sandy Macrae Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2022
BUY
Grant, award, or other acquisition
-
224,000 Added 30.06%
521,176 Common Stock
Feb 25 2021
SELL
Payment of exercise price or tax liability
$395,130 $11.19 p/Share
35,311 Reduced 14.47%
208,691 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
138,375 Added 28.51%
347,066 Common Stock
Jan 24 2021
SELL
Payment of exercise price or tax liability
$59,456 $14.95 p/Share
3,977 Reduced 1.6%
244,002 Common Stock
SM

Sandy Macrae

PRESIDENT, CEO AND DIRECTOR
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGMO